BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Vivimed Labs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -3.80 | -5.35 | -39.56 | -8.17 | -3.52 | |
| Diluted EPS (Rs.) | -3.69 | -5.20 | -38.40 | -7.93 | -3.42 | |
| Cash EPS (Rs.) | -1.55 | -3.13 | -26.67 | -6.07 | -0.90 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 2.47 | 6.20 | 11.50 | 50.57 | 58.67 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 7.05 | 10.78 | 16.08 | 55.15 | 63.25 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 12.50 | 16.50 | 21.33 | 26.34 | 25.33 | |
| PBDIT/Share (Rs.) | -1.25 | -2.20 | -22.67 | -0.96 | 4.07 | |
| PBIT/Share (Rs.) | -3.49 | -4.42 | -35.56 | -3.06 | 2.17 | |
| PBT/Share (Rs.) | -3.80 | -4.65 | -39.81 | -7.83 | -2.84 | |
| Net Profit/Share (Rs.) | -3.80 | -5.35 | -39.56 | -8.17 | -2.81 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -9.97 | -13.33 | -106.28 | -3.64 | 16.07 | |
| PBIT Margin (%) | -27.95 | -26.79 | -166.74 | -11.63 | 8.55 | |
| PBT Margin (%) | -30.40 | -28.18 | -186.69 | -29.73 | -11.19 | |
| Net Profit Margin (%) | -30.40 | -32.44 | -185.49 | -31.02 | -11.08 | |
| Return on Networth / Equity (%) | -153.70 | -86.33 | -344.12 | -16.15 | -4.78 | |
| Return on Capital Employed (%) | -11.78 | -12.62 | -78.32 | -3.59 | 2.35 | |
| Return on Assets (%) | -4.92 | -6.51 | -41.40 | -6.32 | -2.12 | |
| Total Debt/Equity (X) | 18.29 | 7.30 | 3.95 | 0.85 | 0.52 | |
| Asset Turnover Ratio (%) | 0.16 | 0.19 | 0.19 | 0.20 | 0.19 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.63 | 0.70 | 0.64 | 1.21 | 1.39 | |
| Quick Ratio (X) | 0.49 | 0.54 | 0.46 | 0.55 | 0.62 | |
| Inventory Turnover Ratio (X) | 1.74 | 1.21 | 1.16 | 0.58 | 0.36 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 428.60 | 469.98 | 376.20 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 2.42 | 2.15 | 1.79 | |
| EV/EBITDA (X) | 0.00 | 0.00 | -2.28 | -59.05 | 11.14 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.31 | 0.55 | 0.63 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.58 | 0.29 | 0.27 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.31 | 0.55 | 0.63 | |
| Earnings Yield | 0.00 | 0.00 | -5.93 | -0.57 | -0.18 |
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y